The alliance is set to broaden SGI’s platform, which provides specialised funding solutions for clinical trials. Credit: THICHA SATAPITANON/Shutterstock.
Singapore-based SPRIM Global Investments (SGI) and One Investment Management (OneIM) have announced a $300m joint venture (JV) to expedite financing for clinical trials.
This alliance is set to broaden SGI’s TrialCap platform, which provides specialised funding solutions for clinical trials ranging from Phase I through Phase III.
TrialCap’s two decades of industry ‘expertise’ is set to offer flexible and financial backing to medtech and biotech firms. This is expected to assist these companies in progressing their therapies and bringing treatments to market sooner.
SGI managing partner and co-founder Michael Shleifer said: “Our mission is to remove financial barriers that hinder biotech and medtech companies from focusing on research and development.
“Through this strategic partnership with OneIM, we are significantly expanding our ability to provide critical financing solutions that drive innovation in life sciences.”
SGI, established in 2008, is a private investment firm with a focus on clinical-stage life sciences and pharmaceutical services.
Its investment model is designed to offer “agile” financing to biotech companies globally, thereby backing the trial progression and the development of transformative treatments.
OneIM is an alternative investment manager that invests across various asset classes and industries and its team operates from offices in London, Abu Dhabi, Tokyo and New York.
Founded in 2022, it manages assets worth approximately $7bn.
OneIM partner Matt Ross said: “We see tremendous opportunities in the life sciences sector and are delighted to collaborate with SGI, a firm that has a proven track record, deep connectivity across the healthcare ecosystem, and a strong pipeline of opportunities.
“We look forward to accelerating the growth of this platform alongside Michael and the team.”
Email newsletter icon
Sign up for our daily news round-up!
Give your business an edge with our leading industry insights.